H19 lncRNA, once recognized for its tumor-suppressive role, is now associated with the activation of lung, breast, and head-and-neck cancers, as well as promoting cell growth and proliferation in bladder and hepatocellular carcinoma (HCC) (72–74). Here, H19 is linked to hepatocellular carcinoma.